BANK VONTOBEL/CALL/MERCK & CO./110/0.1/20.09.24 Stock

Warrant

DE000VM7N461

Delayed Deutsche Boerse AG 04:13:40 2024-06-28 am EDT
2.08 EUR +6.67% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./110/0.1/20.09.24
Current month+19.63%
1 month-1.52%
Date Price Change
24-06-28 2.08 +6.67%
24-06-27 1.95 -15.58%
24-06-26 2.31 -1.70%
24-06-25 2.35 +3.07%
24-06-24 2.28 +10.68%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:47 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7N46
ISINDE000VM7N461
Date issued 2023-12-29
Strike 110 $
Maturity 2024-09-20 (85 Days)
Parity 10 : 1
Emission price 0.77
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.41
Lowest since issue 0.74
Delta0.86x
Omega 5.029
Premium1.76x
Gearing5.87x
Moneyness 1.180
Difference Strike -19.82 $
Difference Strike %-18.02%
Spread 0.01
Spread %0.48%
Intrinsic value 1.852

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.8 USD
Average target price
142.7 USD
Spread / Average Target
+9.91%
Consensus